How to buy Spruce Biosciences stock

Spruce Biosciences, Inc is a biotechnology business based in the US. Spruce Biosciences shares (SPRB) are listed on the NASDAQ and all prices are listed in US Dollars. Spruce Biosciences employs 15 staff and has a market cap (total outstanding shares value) of USD$463.3 million.

How to buy shares in Spruce Biosciences

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Spruce Biosciences. Find the stock by name or ticker symbol: SPRB. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Spruce Biosciences reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Spruce Biosciences, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Spruce Biosciences. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Building a portfolio

Sofi Invest

Our top pick for

Advanced investors

Webull

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
• Our pick for active investors. We picked Webull for this category because its platform offers features that cater to advancing investors as well as beginners. The desktop app is outfitted with an extensive set of research tools, the mobile app gets high grades from users and traders can test strategies with a paper-trading feature.

What's in this guide?

1. SPRB shares summary
2. Compare share dealing platforms
3. Is SPRB stock a buy or sell?
4. Stock performance over time
5. Can I short SPRB shares?
6. Spruce Biosciences's financials
7. Does Spruce Biosciences pay a dividend?
8. Other common questions

Spruce Biosciences share price

Use our graph to track the performance of SPRB stocks over time.

Spruce Biosciences shares at a glance

• Key figures

Information last updated 2021-03-03.

52-week range	USD$15 - USD$31.25
50-day moving average	USD$21.3026
200-day moving average	USD$21.7982
Wall St. target price	USD$33.75
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	N/A

Buy Spruce Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Webull		$0	Stocks, Options, ETFs	$0	0%	Get two free stock valued between $2.50 and $250 Open an account	Margin financing rates start at 3.99%. No monthly subscription fees for margin.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Spruce Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Spruce Biosciences, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting Spruce Biosciences shares

There are currently 377,342 Spruce Biosciences shares held short by investors – that's known as Spruce Biosciences's "short interest". This figure is 1.3% down from 382,454 last month.

There are a few different ways that this level of interest in shorting Spruce Biosciences shares can be evaluated.

Spruce Biosciences's "short interest ratio" (SIR)

Spruce Biosciences's "short interest ratio" (SIR) is the quantity of Spruce Biosciences shares currently shorted divided by the average quantity of Spruce Biosciences shares traded daily (recently around 37734.2). Spruce Biosciences's SIR currently stands at 10. In other words for every 100,000 Spruce Biosciences shares traded daily on the market, roughly 10000 shares are currently held short.

To gain some more context, you can compare Spruce Biosciences's short interest ratio against those of similar companies.

• Insulet Corporation (PODD.US): 4.72
• Nemaura Medical (NMRD.US): 0.57
• Moderna (MRNA.US): 0.99

However Spruce Biosciences's short interest can also be evaluated against the total number of Spruce Biosciences shares, or, against the total number of tradable Spruce Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Spruce Biosciences's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Spruce Biosciences shares in existence, roughly 20 shares are currently held short) or 0.0211% of the tradable shares (for every 100,000 tradable Spruce Biosciences shares, roughly 21 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Spruce Biosciences.

Find out more about how you can short Spruce Biosciences stock.

Spruce Biosciences overview

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company develops tildacerfont, an non-steroidal therapy, which is in Phase IIb clinical trial for adult patients with classic congenital adrenal hyperplasia (CAH) and in Phase II clinical trial in children with classic CAH. It is also developing tildacerfont for females with polycystic ovary syndrome. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was founded in 2014 and is headquartered in Daly City, California.

Frequently asked questions

• What percentage of Spruce Biosciences is owned by insiders or institutions?

  Currently 11.23% of Spruce Biosciences shares are held by insiders and 51.013% by institutions.

• How many people work for Spruce Biosciences?

  Latest data suggests 15 work at Spruce Biosciences.

• When does the fiscal year end for Spruce Biosciences?

  Spruce Biosciences's fiscal year ends in December.

• Where is Spruce Biosciences based?

  Spruce Biosciences's address is: 2001 Junipero Serra Boulevard, Daly City, CA, United States, 94014

• What is Spruce Biosciences's ISIN number?

  Spruce Biosciences's international securities identification number is: US85209E1091